Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19) ; volume:18 ; number:1 ; day:25 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (25.6.2020), 1-9, 12.2020
- Urheber
-
Kim, Jason
Zhang, Jenny
Cha, Yoonjeong
Kolitz, Sarah
Funt, Jason
Escalante Chong, Renan
Barrett, Scott
Kusko, Rebecca
Zeskind, Ben
Kaufman, Howard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-020-02430-9
- URN
-
urn:nbn:de:101:1-2020082119594250001198
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Jason
- Zhang, Jenny
- Cha, Yoonjeong
- Kolitz, Sarah
- Funt, Jason
- Escalante Chong, Renan
- Barrett, Scott
- Kusko, Rebecca
- Zeskind, Ben
- Kaufman, Howard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Pooled effector library screening in protoplasts rapidly identifies novel Avr genes
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
A protein interaction map identifies existing drugs targeting SARS-CoV-2
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics